Cargando…
The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
BACKGROUND: The expression of CD56 is considered a bad prognostic factor for overall survival, lower rates or short complete remission and extramedullary invasion but the results are controversial. The importance of validating new prognostic parameters in acute leukemias was the reason to investigat...
Autores principales: | Alegretti, Ana Paula, Bittar, Christina Matzenbacher, Bittencourt, Rosane, Piccoli, Amanda Kirchner, Schneider, Laiana, Silla, Lúcia Mariano, Bó, Suzane Dal, Xavier, Ricardo Machado |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Hematologia e Hemoterapia
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415729/ https://www.ncbi.nlm.nih.gov/pubmed/23049296 http://dx.doi.org/10.5581/1516-8484.20110054 |
Ejemplares similares
-
Diminished Expression of Complement Regulatory Proteins on Peripheral Blood Cells from Systemic Lupus Erythematosus Patients
por: Alegretti, Ana Paula, et al.
Publicado: (2012) -
The expression of the CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
por: Rego, Eduardo Magalhães
Publicado: (2011) -
Detection of Minimal Residual Disease by Flow Cytometry for Patients with Multiple Myeloma Submitted to Autologous Hematopoietic Stem Cell Transplantation
por: Dal Bó, Suzane, et al.
Publicado: (2013) -
DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil
por: Pezzi, Annelise, et al.
Publicado: (2012) -
Erratum to “DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil”
por: Pezzi, Annelise, et al.
Publicado: (2014)